Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

cytisine MeSH Supplementary Concept Data 2025


MeSH Supplementary
cytisine
Unique ID
C004712
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C004712
Entry Term(s)
3-hydroxy-11-norcytisine
Tabex
Tsitizin
citizine
cystisin
cytisine dihydrochloride, trihydrate
cytisine hydrochloride
cytisine hydrochloride, hydrate
cytisine tetrahydrochloride, trihydrate
cytiton
Registry Numbers
53S5U404NU
6013-61-2
6018-49-1
6018-50-4
6047-01-4
Related Numbers
485-35-8
6013-61-2
6018-49-1
6018-50-4
6047-01-4
CAS Type 1 Name
1,2,3,4,5,6-hexahydro-1,5-methano-8H- pyrido(1,2-a)(1,5)diazocin-8-one
Previous Indexing
*ALKALOIDS (1982-2022)
*AZOCINES (69-81)
PYRIDINES (71-76)
Quinolizines (1982-2022)
Heading Mapped to
*Quinolizidine Alkaloids
Frequency
467
Note
RN given refers to (R)-isomer; structure
Source
Acta Polon Pharm 29(5):490;1972
Biokhimiia 43(7):1150;1978
Indexing Information
Nicotine
Date of Entry
1969/01/01
Revision Date
2022/11/02
cytisine Preferred
Tsitizin Narrower
cytisine hydrochloride, hydrate Narrower
cytisine dihydrochloride, trihydrate Narrower
cytisine tetrahydrochloride, trihydrate Narrower
cytisine hydrochloride Narrower
Tabex Narrower
3-hydroxy-11-norcytisine Related
page delivered in 0.007s